181 related articles for article (PubMed ID: 33592381)
21. Estimated prevalence and incidence of multiple sclerosis in Iran.
Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.
Azami M; YektaKooshali MH; Shohani M; Khorshidi A; Mahmudi L
PLoS One; 2019; 14(4):e0214738. PubMed ID: 30964886
[TBL] [Abstract][Full Text] [Related]
23. Geographic variations of multiple sclerosis in Iran: A population based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Mult Scler Relat Disord; 2019 Feb; 28():244-249. PubMed ID: 30634104
[TBL] [Abstract][Full Text] [Related]
24. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.
Brola W; Sobolewski P; Flaga S; Fudala M; Szczuchniak W; Stoiński J; Rosołowska A; Wójcik J; Kapica-Topczewska K; Ryglewicz D
BMC Neurol; 2016 Aug; 16(1):134. PubMed ID: 27516084
[TBL] [Abstract][Full Text] [Related]
26. The changing face of multiple sclerosis: Prevalence and incidence in an aging population.
Solaro C; Ponzio M; Moran E; Tanganelli P; Pizio R; Ribizzi G; Venturi S; Mancardi GL; Battaglia MA
Mult Scler; 2015 Sep; 21(10):1244-50. PubMed ID: 25583850
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of multiple sclerosis in Lebanon: A rising prevalence in the middle east.
Zeineddine M; Hajje AA; Hussein A; El Ayoubi N; Yamout B
Mult Scler Relat Disord; 2021 Jul; 52():102963. PubMed ID: 33934011
[TBL] [Abstract][Full Text] [Related]
28. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
29. A 12-year trend analysis of the incidence of gastrointestinal cancers in East Azerbaijan: last updated results of an ongoing population-based cancer registry.
Somi MH; Dolatkhah R; Sepahi S; Belalzadeh M; Naghashi S; Asghari Jafarabadi M
BMC Cancer; 2019 Aug; 19(1):782. PubMed ID: 31391032
[TBL] [Abstract][Full Text] [Related]
30. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
O'Connell K; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
[TBL] [Abstract][Full Text] [Related]
31. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Maghzi AH; Ghazavi H; Ahsan M; Etemadifar M; Mousavi S; Khorvash F; Minagar A
Mult Scler; 2010 Mar; 16(3):359-61. PubMed ID: 20086021
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.
Izadi S; Nikseresht AR; Poursadeghfard M; Borhanihaghighi A; Heydari ST
Iran J Med Sci; 2015 Sep; 40(5):390-5. PubMed ID: 26379344
[TBL] [Abstract][Full Text] [Related]
33. The trend of incidence, prevalence, and DALY of multiple sclerosis in the Middle East and Northern Africa region compared to global, West Europe and, Iran's corresponding values during 1990-2017: Retrieved from global burden of diseases data.
Abbastabar H; Bitarafan S; Mohammadpour Z; Mohammadianinejad SE; Harirchian MH
Mult Scler Relat Disord; 2021 Jul; 52():102949. PubMed ID: 33894481
[TBL] [Abstract][Full Text] [Related]
34. Increasing prevalence and incidence of multiple sclerosis in Poland.
Brola W; Sobolewski P; Flaga S; Fudala M; Jantarski K
Neurol Neurochir Pol; 2017; 51(1):82-85. PubMed ID: 27889289
[TBL] [Abstract][Full Text] [Related]
35. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey.
Ranzato F; Perini P; Tzintzeva E; Tiberio M; Calabrese M; Ermani M; Davetag F; De Zanche L; Garbin E; Verdelli F; Villacara A; Volpe G; Moretto G; Gallo P
Mult Scler; 2003 Aug; 9(4):387-92. PubMed ID: 12926844
[TBL] [Abstract][Full Text] [Related]
36. A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
Grytten N; Aarseth JH; Lunde HM; Myhr KM
J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):100-5. PubMed ID: 25714916
[TBL] [Abstract][Full Text] [Related]
37. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Kingwell E; Zhu F; Marrie RA; Fisk JD; Wolfson C; Warren S; Profetto-McGrath J; Svenson LW; Jette N; Bhan V; Yu BN; Elliott L; Tremlett H
J Neurol; 2015 Oct; 262(10):2352-63. PubMed ID: 26205633
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of multiple sclerosis in Iran: a systematic review.
Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
[TBL] [Abstract][Full Text] [Related]
39. Spatial autocorrelation and epidemiological survey of visceral leishmaniasis in an endemic area of Azerbaijan region, the northwest of Iran.
Adham D; Moradi-Asl E; Dorosti A; Khaiatzadeh S
PLoS One; 2020; 15(8):e0236414. PubMed ID: 32845890
[TBL] [Abstract][Full Text] [Related]
40. The Association between Diet and Multiple Sclerosis.
Asgharzadeh V; Rezaei SAS; Poor BM; Asgharzadeh M; Nobari HJ; Taghinejad Z; Kazemi A; Rashedi J
Endocr Metab Immune Disord Drug Targets; 2024; 24(8):909-917. PubMed ID: 37933212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
